Inkoop Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-05-2024
- Paid Up Capital ₹ 0.10 M
as on 21-05-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Inkoop Pharma
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharat Sharma and Chetan Sharma serve as directors at the Company.
- CIN/LLPIN
U24230WB2021PTC245890
- Company No.
245890
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2021
- Date of AGM
23 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Inkoop Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Sharma  | Director | 21-Jun-2021 | Current |
| Chetan Sharma | Director | 21-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Inkoop Pharma.
Inkoop Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Inkoop Pharma?
Unlock access to Inkoop Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aristo Textiles Private LimitedActive 14 years 10 monthsBharat Sharma and Chetan Sharma are mutual person
- Boon Healthcare Private LimitedActive 3 years 6 months
Bharat Sharma and Chetan Sharma are mutual person
- Heedkeep Remedies Private LimitedActive 3 years 5 months
Bharat Sharma and Chetan Sharma are mutual person
- Credible Medicos Private LimitedActive 3 years 5 months
Bharat Sharma and Chetan Sharma are mutual person
- Dd Infrastructures Private LimitedActive 26 years 10 months
Bharat Sharma and Chetan Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inkoop Pharma?
Inkoop Pharma has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inkoop Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inkoop Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
